<?xml version="1.0" encoding="UTF-8"?>
<p id="P56">Inhaled zanamivir is well tolerated.
 <sup>
  <xref ref-type="bibr" rid="R106">106</xref>
 </sup> Acute bronchospasm with decline in respiratory function has been reported; a bronchodilator should be available if given as treatment for patients with underlying pulmonary disease. Other adverse effects include headache and gastrointestinal symptoms. Hypersensitivity reactions and neuropsychiatric adverse effects occur rarely.
 <sup>
  <xref ref-type="bibr" rid="R109">109</xref>
 </sup>
</p>
